Skip to main content
Erschienen in: Rheumatology International 10/2013

01.10.2013 | Short Communication

Meigs’ syndrome: a rare cause of recurrent pleural effusion in scleroderma

verfasst von: Feng Su, Kristopher W. Cummings, Hannah Krigman, Prabha Ranganathan

Erschienen in: Rheumatology International | Ausgabe 10/2013

Einloggen, um Zugang zu erhalten

Abstract

Meigs’ syndrome represents a triad of pleural effusion, ascites, and an ovarian tumor, usually benign, occurring together. We describe here a case of Meigs’ syndrome in a patient with systemic sclerosis, the first such report to our knowledge, in systemic sclerosis. A 53-year-old woman with systemic sclerosis presented with recurrent right-sided pleural effusion, which led to symptoms of shortness of breath, chest tightness, and a non-productive cough. Physical examination revealed a palpable, mobile mass in the right lower quadrant, in addition to typical physical features of scleroderma. Thoracentesis yielded exudative pleural fluid with cytology negative for malignancy. Pleural biopsy was consistent with inflammatory changes, but negative for malignancy. CT scan of the chest, abdomen, and pelvis revealed a soft tissue mass in the pelvis, which appeared to arise from the left ovary. The patient’s cancer antigen 125 (CA-125) level was elevated at 222 U/mL (normal range, 0–30 U/mL). The patient underwent a total abdominal hysterectomy and bilateral salpingo-oophorectomy. Histology of the left ovarian mass was consistent with an ovarian fibrothecoma, a benign tumor of the ovary. At her 1-month follow-up appointment, the patient had complete resolution of the right-sided pleural effusion. To date, at 10 months past the initial presentation, she has not had recurrence of pleural effusion. Although rare, Meigs’ syndrome should be considered as a possible cause of recurrent serositis in women with rheumatologic diseases. Removal of the ovarian tumor leads to prompt resolution of the serositis.
Literatur
1.
Zurück zum Zitat Brun J (2007) Demons syndrome revisited: a review of the literature. Gynecol Oncol 105:796–800PubMedCrossRef Brun J (2007) Demons syndrome revisited: a review of the literature. Gynecol Oncol 105:796–800PubMedCrossRef
2.
Zurück zum Zitat Meigs JV, Cass J (1937) Fibroma of ovary with ascites and hydrothorax. Am J Obstet Gynecol 33:249–267 Meigs JV, Cass J (1937) Fibroma of ovary with ascites and hydrothorax. Am J Obstet Gynecol 33:249–267
3.
Zurück zum Zitat Meigs JV (1954) Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol 3:471–486PubMed Meigs JV (1954) Pelvic tumors other than fibromas of the ovary with ascites and hydrothorax. Obstet Gynecol 3:471–486PubMed
4.
Zurück zum Zitat Chechia A, Attia L, Ben Temime R, Makhlouf T, Koubaa A (2008) Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas. Am J Obstet Gynecol 199:473.e1–473.e4CrossRef Chechia A, Attia L, Ben Temime R, Makhlouf T, Koubaa A (2008) Incidence, clinical analysis, and management of ovarian fibromas and fibrothecomas. Am J Obstet Gynecol 199:473.e1–473.e4CrossRef
5.
Zurück zum Zitat Ural UM, Kiliç A, Güngör T, Özdal B, Mollamahmutoğlu L (2008) Tjalma’s or pseudo–pseudo-Meigs’ syndrome: a case report. Clin Exp Dermatol 33:363–364PubMedCrossRef Ural UM, Kiliç A, Güngör T, Özdal B, Mollamahmutoğlu L (2008) Tjalma’s or pseudo–pseudo-Meigs’ syndrome: a case report. Clin Exp Dermatol 33:363–364PubMedCrossRef
6.
Zurück zum Zitat Schmitt R, Weichert W, Schneider W, Luft FC, Kettritz R (2005) Pseudo-pseudo Meig’s syndrome. Lancet 366:1672PubMedCrossRef Schmitt R, Weichert W, Schneider W, Luft FC, Kettritz R (2005) Pseudo-pseudo Meig’s syndrome. Lancet 366:1672PubMedCrossRef
7.
Zurück zum Zitat Thompson AE, Pope JE (1998) A study of the frequency of pericardial and pleural effusions in scleroderma. Br J Rheumatol 37:1320–1323PubMedCrossRef Thompson AE, Pope JE (1998) A study of the frequency of pericardial and pleural effusions in scleroderma. Br J Rheumatol 37:1320–1323PubMedCrossRef
8.
Zurück zum Zitat Taormina VJ, Miller WT, Gefter WB, Epstein DM (1981) Progressive systemic sclerosis subgroups: variable pulmonary features. Am J Roentgenol 137:277–285CrossRef Taormina VJ, Miller WT, Gefter WB, Epstein DM (1981) Progressive systemic sclerosis subgroups: variable pulmonary features. Am J Roentgenol 137:277–285CrossRef
9.
Zurück zum Zitat Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101:59–62PubMedCrossRef Wooten M (2008) Systemic sclerosis and malignancy: a review of the literature. South Med J 101:59–62PubMedCrossRef
10.
Zurück zum Zitat Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T (2001) Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 21:106–111PubMedCrossRef Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T (2001) Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 21:106–111PubMedCrossRef
11.
Zurück zum Zitat Derk CT, Rasheed M, Artlett CM, Jimenez SA (2006) A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33:1113–1116PubMed Derk CT, Rasheed M, Artlett CM, Jimenez SA (2006) A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33:1113–1116PubMed
12.
13.
Zurück zum Zitat Kawakami Y, Nakamura K, Nakamura-Wakatsuki T, Ohtsuka M, Oyama N, Kaneko F (2007) Systemic sclerosis complicated by ovarian cancer. J Dermatol 34:720–723PubMedCrossRef Kawakami Y, Nakamura K, Nakamura-Wakatsuki T, Ohtsuka M, Oyama N, Kaneko F (2007) Systemic sclerosis complicated by ovarian cancer. J Dermatol 34:720–723PubMedCrossRef
14.
Zurück zum Zitat Aoshima M, Tanaka H, Takahashi M, Nakamura K, Makino I (1995) Meigs’ syndrome due to Brenner tumor mimicking lupus peritonitis in a patient with systemic lupus erythematosus. Am J Gastroenterol 90:657–658PubMed Aoshima M, Tanaka H, Takahashi M, Nakamura K, Makino I (1995) Meigs’ syndrome due to Brenner tumor mimicking lupus peritonitis in a patient with systemic lupus erythematosus. Am J Gastroenterol 90:657–658PubMed
15.
Zurück zum Zitat Widra EA, Armstrong J (1995) Pseudo-Meigs’ syndrome and lupus. Int J Gynaecol Obstet 49:193–194PubMedCrossRef Widra EA, Armstrong J (1995) Pseudo-Meigs’ syndrome and lupus. Int J Gynaecol Obstet 49:193–194PubMedCrossRef
16.
17.
Zurück zum Zitat Abramov Y, Anteby SO, Fasouliotis SJ, Barak V (2002) The role of inflammatory cytokines in Meigs’ syndrome. Obstet Gynecol 99:917–919PubMedCrossRef Abramov Y, Anteby SO, Fasouliotis SJ, Barak V (2002) The role of inflammatory cytokines in Meigs’ syndrome. Obstet Gynecol 99:917–919PubMedCrossRef
18.
Zurück zum Zitat Angelo LS, Kurzrock R (2007) Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13:2825–2830PubMedCrossRef Angelo LS, Kurzrock R (2007) Vascular endothelial growth factor and its relationship to inflammatory mediators. Clin Cancer Res 13:2825–2830PubMedCrossRef
19.
Zurück zum Zitat Abramov Y, Anteby SO, Fasouliotis SJ, Barak V (2001) Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Obstet Gynecol 184:354–355CrossRef Abramov Y, Anteby SO, Fasouliotis SJ, Barak V (2001) Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Obstet Gynecol 184:354–355CrossRef
20.
Zurück zum Zitat McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV Jr et al (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344:235–236PubMedCrossRef McClure N, Healy DL, Rogers PA, Sullivan J, Beaton L, Haning RV Jr et al (1994) Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome. Lancet 344:235–236PubMedCrossRef
Metadaten
Titel
Meigs’ syndrome: a rare cause of recurrent pleural effusion in scleroderma
verfasst von
Feng Su
Kristopher W. Cummings
Hannah Krigman
Prabha Ranganathan
Publikationsdatum
01.10.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 10/2013
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2437-x

Weitere Artikel der Ausgabe 10/2013

Rheumatology International 10/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.